利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

5 条记录 (耗时 0.018 秒)

    Method and apparatus for charging a nickel-cadmium battery
    1.
    发明授权
    Method and apparatus for charging a nickel-cadmium battery 失效
    镍镉电池充电方法和装置

    公开(公告)号：US4806840A

    公开(公告)日：1989-02-21

    申请号：US941592

    申请日：1986-12-15

    申请人： Richard B. Alexander ,  Dennis P. Kindschuh

    发明人： Richard B. Alexander ,  Dennis P. Kindschuh

    IPC分类号： H01M10/44 ,  H02J7/00 ,  H02J7/10

    CPC分类号： H01M10/44 ,  H02J7/0081

    摘要： The characteristic voltage-versus-time curve for a nickel-cadmium battery on a fast charge, e.g., being charged at the C/1 rate, increases to a peak voltage and thereafter decreases. To ensure that the battery is fully charged, the fast charge is discontinued on the decreasing portion of the voltage-versus-time curve. The fast charge may be stopped when a predetermined negative rate of change of the voltage is obtained. Or the fast charge may be cut off when the battery voltage decreases a predetermined amount below the peak, that is, when the difference between the maximum measured battery voltage and the present battery voltage exceeds a setpoint. After the fast charge is discontinued, a trickle charge, e.g., a C/10 charge or less, may be instituted or the charging current may be interrupted altogether, i.e., the battery charging circuit may be opened.

    摘要翻译： 例如以C / 1速率充电的镍镉电池的快速充电的特征电压 - 时间曲线增加到峰值电压，然后减小。 为了确保电池完全充电，在电压 - 时间曲线的减少部分停止快速充电。 当获得预定的负变化率时，可以停止快速充电。 或者当电池电压降低到低于峰值的预定量时，即当最大测量电池电压与当前电池电压之间的差异超过设定值时，快速充电可能被切断。 在快速充电停止之后，可以进行涓流充电，例如C / 10充电或更少充电，或者可以完全中断充电电流，即，可以打开电池充电电路。

    Method for diagnosing and treating chronic pelvic pain syndrome
    3.
    发明授权
    Method for diagnosing and treating chronic pelvic pain syndrome 失效
    诊断和治疗慢性盆腔疼痛综合征的方法

    公开(公告)号：US06180355B2

    公开(公告)日：2001-01-30

    申请号：US09306927

    申请日：1999-05-07

    申请人： Richard B. Alexander ,  Sathibalan Ponniah

    发明人： Richard B. Alexander ,  Sathibalan Ponniah

    IPC分类号： G01N3350

    CPC分类号： G01N33/6863 ,  A61K38/1793

    摘要： The present invention provides a superior method of diagnosing Chronic Pelvic Pain Syndrome in men comprising measuring levels of cytokines in semen or components or fractions of semen. The invention also provides a method of treating a condition associated with elevated levels of a cytokine, such as TNF-&agr;, in semen or a component or fraction thereof, comprising administering a therapeutically effective amount of an ant-cytokine compound or composition, such as an anti-TNF-&agr; compound or composition.

    摘要翻译： 本发明提供了一种诊断男性慢性骨盆疼痛综合征的优良方法，包括测量精液中精液或成分或精馏分数的细胞因子水平。 本发明还提供了一种治疗与精液或其组分或部分中的细胞因子如TNF-α水平升高相关的病症的方法，包括施用治疗有效量的抗细胞因子化合物或组合物，例如 抗TNF-α化合物或组合物。

    Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer
    5.
    发明申请
    Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer 审中-公开
    前列腺酸性磷酸酶（Pap）材料及其使用方法在前列腺癌的预防和治疗中的应用

    公开(公告)号：US20080219972A1

    公开(公告)日：2008-09-11

    申请号：US12063765

    申请日：2006-08-16

    申请人： Elena N. Klyushnenkova ,  Richard B. Alexander

    发明人： Elena N. Klyushnenkova ,  Richard B. Alexander

    IPC分类号： A61K39/395 ,  C07H21/00 ,  A61K39/00 ,  C12N9/14 ,  C12N5/06 ,  A61P13/00 ,  A61K38/46 ,  A61K35/12 ,  C07K16/18

    CPC分类号： A61K39/0011 ,  A61K2039/5154 ,  C12N9/14

    摘要： A nucleic acid molecule comprising at least one nucleotide sequence encoding SEQ ID NO: 14, 15, 19, 41, or a sequence that is at least about 95% identical thereto; a composition comprising same and a method of administering same to induce an immune response; a polypeptide consisting of SEQ ID NO: 14, 15, 19, 41, or a sequence that is at least about 95% identical thereto; a composition comprising same and a method of administering same to induce an immune response; a composition comprising APC, which have been exposed to the polypeptide, and a method of administering same to treat prostate cancer; a composition comprising T-cells, which are specific for an epitope in a polypeptide consisting of SEQ ID NO: 14, 15, 19, or 41 and a method of administering same to treat prostate cancer; a composition comprising an anti-idiotypic antibody having an internal image of an epitope of a polypeptide consisting of SEQ ID NO: 14, 15, 19, or 41 and a method of administering same to treat prostate cancer; and an immortal B-cell line that produces an anti-idiotypic monoclonal antibody having an internal image of an epitope of a polypeptide consisting of SEQ ID NO: 14, 15, 19, or 41.

    摘要翻译： 核酸分子，其包含至少一个编码SEQ ID NO：14,15,19,41的核苷酸序列或与其至少约95％同一性的序列; 包含其组合物的组合物和施用其以诱导免疫应答的方法; 由SEQ ID NO：14,15,19,41组成的多肽或与其至少约95％同一性的序列; 包含其组合物的组合物和施用其以诱导免疫应答的方法; 已经暴露于多肽的包含APC的组合物以及其治疗前列腺癌的方法; 包含T细胞的组合物，其对由SEQ ID NO：14,15,19或41组成的多肽中的表位是特异性的，以及其给予治疗前列腺癌的方法; 包含具有由SEQ ID NO：14,15,19或41组成的多肽的表位的内部图像的抗独特型抗体的组合物及其治疗前列腺癌的方法; 以及产生具有由SEQ ID NO：14,15,19或41组成的多肽的表位的内部图像的抗独特型单克隆抗体的不朽B细胞系。